SERPINA3 and metabolic dysfunction-associated steatohepatitis: As endogenous levels of Serpina3k or SERPINA3 were pathologically reduced in the livers of FPC- or CDAHFD-fed WT mice and patients with MASH, we hypothesized that restoring Serpina3k/SERPINA3 could reverse hepatic steatohepatitis.